The number of biopharma and biotech companies developing and launching new therapies is continuing to rise with emerging biopharma remaining a strong source of innovation. Learn how IQVIA is helping clinical and commercial customers bring therapies to market and to the patients who need them.
IQVIA experts will break down the components of successful commercialization for emerging biopharma and biotech companies.
Michael Kleinrock
Research Director, IQVIA Institute for Human Data Science
William McClellan
Vice President, Practice Leader, Launch & Thought Leader Networks, Center of Excellence, IQVIA
Michael Kardas
Vice President, Strategic Drug Development, IQVIA
Flexible solutions. Responsive teams. Data-driven insights.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
